DIA Biosimilars 2013

Astellas

Report: Boston, N.J., Bay area lead nation’s top 16 life sciences clusters, all are growing

Monday, December 5, 2011 09:18 AM

Move over Boston, New Jersey and the San Francisco Bay area. Los Angeles and the Washington, D.C., region are quickly gathering steam as established life sciences hubs. And Minneapolis, Chicago, Denver, Houston, Florida, Atlanta and Indianapolis are among the emerging hubs not far behind. 

More... »

Cenduit: Now with Patient Reminders

Astellas discontinues darexaban

Wednesday, September 28, 2011 01:47 PM

Astellas Pharma has decided to discontinue the global development of darexaban maleate, an oral direct Factor Xa inhibitor for all indications.

More... »

CRF Health – eCOA Forum

Verasteam names Pachter VP, head of research

Thursday, August 4, 2011 01:11 PM

Verastem has named Jonathan Pachter, Ph.D., vice president and head of research.

More... »

Astellas to sell diabetes patents

Friday, July 1, 2011 10:13 AM

Japanese drug maker Astellas Pharma is selling its diabetes-related patents to a fund for $609 million, to then be invested in strategic initiatives, according to Reuters.

More... »

Astellas adds four to team

Tuesday, May 3, 2011 12:33 PM

Astellas Pharma Global Development, a subsidiary of Tokyo-based Astellas Pharma, welcomes four new industry leaders to its team.

More... »

Astellas Pharma Europe appoints Ken Jones as president and CEO

Monday, April 11, 2011 12:34 PM

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Ken Jones as its president and CEO.  Jones was formerly COO at Astellas Pharma Europe.

More... »

Astellas exercises buy-out option for Perseid

Friday, March 18, 2011 01:35 PM

Astellas Pharma has exercised a buy-out option to acquire all of Maxygen’s ownership interest in Perseid Therapeutics, the joint venture between Maxygen and Astellas, according to Fierce Biotech.  Maxygen and Perseid are based in Redwood City, Calif.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs